Bacterial Infections  >>  Stelara (ustekinumab)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Stelara (ustekinumab) / J&J
NCT01704534: A Proof of Concept Study to Evaluate the Effectiveness of Ustekinumab in Hidradenitis Suppurativa

Completed
2
20
Europe
Ustekinumab, Stelara
University Medical Center Groningen, Janssen-Cilag B.V.
Hidradenitis Suppurativa
01/14
04/14

Download Options